Literature DB >> 15938726

Outcome of holistic care in Nigerian patients with sickle cell anaemia.

O O Akinyanju1, A I Otaigbe, M O O Ibidapo.   

Abstract

Holistic care of patients with sickle cell anaemia (HbSS) was carried out in a dedicated support group and clinic in Lagos. This paper examines the outcome of this initiative using mortality, hospital admission and blood transfusion rates from inception in April 1988 to December 1995. Patients with sickle cell disorder and their families were admitted to the Sickle Cell Club and its associated Sickle Cell Clinic. All patients and parents were counselled on recruitment and were regularly followed up within an interactive family friendly environment. Other measures included preventive health and nutritional education, prompt treatment of illness and free supplies of vitamin supplements, malarial prophylactic and other necessary medication. The records of consecutive patients with HbSS were reviewed for this study. Over the study period, the number of subjects increased from 290 in 1988 to 1223 in 1995. The mortality rate fell from 20.6% in 1988 to 0.6% in 1995 (P < 0.0001); the number of hospital admissions fell from 350 (119%) in 1988 to 30 (4%) in 1995 (P < 0.0001); the number of patients transfused with blood fell from 260 (90%) in 1988 to 25 (2%) in 1995 (P < 0.00001). We conclude that the provision of well-organized holistic care can significantly reduce illness and deaths and improve the quality of lives of people living with HbSS in developing countries.

Entities:  

Mesh:

Year:  2005        PMID: 15938726     DOI: 10.1111/j.1365-2257.2005.00683.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  18 in total

Review 1.  Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

Authors:  Venée N Tubman; Julie Makani
Journal:  Br J Haematol       Date:  2017-05-11       Impact factor: 6.998

2.  The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy.

Authors:  Samuel A Adegoke; Emmanuel A Abioye-Kuteyi; Ernest O Orji
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

3.  Global epidemiology of haemoglobin disorders and derived service indicators.

Authors:  Bernadette Modell; Matthew Darlison
Journal:  Bull World Health Organ       Date:  2008-06       Impact factor: 9.408

4.  High birth prevalence of sickle cell disease in Northwestern Tanzania.

Authors:  Emmanuela E Ambrose; Julie Makani; Neema Chami; Tulla Masoza; Rogatus Kabyemera; Robert N Peck; Erasmus Kamugisha; Alphaxard Manjurano; Neema Kayange; Luke R Smart
Journal:  Pediatr Blood Cancer       Date:  2017-08-02       Impact factor: 3.167

5.  Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient's compliance.

Authors:  Ademola Samson Adewoyin; Omokiniovo Sunday Oghuvwu; Omolade Augustina Awodu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

Review 6.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

7.  Haematology in Africa.

Authors:  Lucio Luzzatto; Foluke Fasola; Léon Tshilolo
Journal:  Br J Haematol       Date:  2011-07-05       Impact factor: 6.998

Review 8.  Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).

Authors:  Ademola Samson Adewoyin
Journal:  Anemia       Date:  2015-01-18

9.  Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality.

Authors:  Julie Makani; Deogratias Soka; Stella Rwezaula; Marlene Krag; Janneth Mghamba; Kaushik Ramaiya; Sharon E Cox; Scott D Grosse
Journal:  Trop Med Int Health       Date:  2014-11-17       Impact factor: 2.622

10.  An observational study of children with sickle cell disease in Kilifi, Kenya.

Authors:  Manish Sadarangani; Julie Makani; Albert N Komba; Tolu Ajala-Agbo; Charles R Newton; Kevin Marsh; Thomas N Williams
Journal:  Br J Haematol       Date:  2009-07-23       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.